Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance
Stuard S. Ridel C. Cioffi M. Trost-Rupnik A. Gurevich K. Bojic M. Karibayev Y. Mohebbi N. Marcinkowski W. Kupres V. Maslovaric J. Antebi A. Ponce P. Nada M. Salvador M.E.B. Rosenberger J. Jirka T. Enden K. Novakivskyy V. Voiculescu D. Pachmann M. Arkossy O.
June 2024Multidisciplinary Digital Publishing Institute (MDPI)
Journal of Clinical Medicine
2024#13Issue 11
The demographic profile of patients transitioning from chronic kidney disease to kidney replacement therapy is changing, with a higher prevalence of aging patients with multiple comorbidities such as diabetes mellitus and heart failure. Cardiovascular disease remains the leading cause of mortality in this population, exacerbated by the cardiovascular stress imposed by the HD procedure. The first year after transitioning to hemodialysis is associated with increased risks of hospitalization and mortality, particularly within the first 90–120 days, with greater vulnerability observed among the elderly. Based on data from clinics in Fresenius Medical Care Europe, Middle East, and Africa NephroCare, this review aims to optimize hemodialysis procedures to reduce mortality risk in stable incident and prevalent patients. It addresses critical aspects such as treatment duration, frequency, choice of dialysis membrane, dialysate composition, blood and dialysate flow rates, electrolyte composition, temperature control, target weight management, dialysis adequacy, and additional protocols, with a focus on mitigating prevalent intradialytic complications, particularly intradialytic hypotension prevention.
dialysis dose , dialysis electrolyte balance , dialysis fluid balance , hemodialysis procedures , hemodynamic stability
Text of the article Перейти на текст статьи
FME Global Medical Office, Bad Homburg, 61352, Germany
FME Global Medical Office, Fresnes, 94260, France
FME Global Medical Office, Napoli, 80133, Italy
FME Global Medical Office, Brezovica pri Ljubljani, 1351, Slovenia
FME Global Medical Office, Saint Petersburg, 194354, Russian Federation
FME Global Medical Office, Bosnia and Herzegovina, Zvornik, 75400, Bosnia and Herzegovina
FME Global Medical Office, Almaty, 050003, Kazakhstan
FME Global Medical Office, Zurich, 8002, Switzerland
FME Global Medical Office, Poznań, 60118, Poland
FME Global Medical Office, Zabok, 49210, Croatia
FME Global Medical Office, Beograd, 11000, Serbia
FME Global Medical Office, Ra’anana 4366411, Israel
FME Global Medical Office, Lisboa, 1750-233, Portugal
FME Global Medical Office, Riyadh, 12472, Saudi Arabia
FME Global Medical Office, Madrid, 28760, Spain
FME Global Medical Office, Košice, 04011, Slovakia
FME Global Medical Office, Praha, 16000, Czech Republic
FME Global Medical Office, Helsinki, 00380, Finland
FME Global Medical Office, Kyiv, 02099, Ukraine
FME Global Medical Office, Bucuresti, 013682, Romania
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
FME Global Medical Office
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026